Excelya
Pharmaceutical ManufacturingÎle-de-france, France501-1000 Employees
Excelya serves biotech, pharmaceutical, and medical device organizations as an independent partner, delivering a broad mix of clinical development services that encompass full-service CRO engagements, functional service provider arrangements, and resourcing options. Founded in 2014 and headquartered in Boulogne-Billancourt, Île-de-France, France, the company operates in 28 countries across Europe, the United States, and India, supported by a global team of more than 900 experts. Its therapeutic focus spans Oncology and Hematology, Rare Disease and Pediatrics, Infectious Diseases, Inflammation and Immunotherapy, Pain Treatment and CNS, and Late Phase studies with Real-World Evidence. The organization serves biotech, pharma, and medical device customers seeking efficient planning, design, and execution of clinical trials through tailored solutions. EcoVadis recognizes Excelya with a Silver Medal in 2024 and Bronze Medal in the 2025/2026 reassessment, and as of February 2026 the group ranks in the top 35% of evaluated companies.
1-888-653-2347 
support@leadiq.com 
